Foreign body in the oesophagus.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 680963)

Published in Indian Pediatr on February 01, 1978

Authors

M Gupta, A Jain, A S Rathore, C Mukesh

Articles by these authors

(truncated to the top 100)

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J Cell Biol (1999) 8.07

Kidney transplantation under FK 506. JAMA (1990) 7.45

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J (2000) 4.41

Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med (2001) 4.01

Implementation of a high-sensitivity Micro-Angiographic Fluoroscope (HS-MAF) for in-vivo endovascular image guided interventions (EIGI) and region-of-interest computed tomography (ROI-CT). Proc SPIE Int Soc Opt Eng (2008) 3.49

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14

Lack of reproducibility in pregnancy of Korotkoff phase IV as measured by mercury sphygmomanometry. Lancet (1996) 3.12

Molecular cloning and expression of the mouse ornithine decarboxylase gene. Proc Natl Acad Sci U S A (1984) 2.83

Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75

Sequence analysis of the DNA encoding the Eco RI endonuclease and methylase. J Biol Chem (1981) 2.62

A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc (1991) 2.49

Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc (1990) 2.48

Maternal feeding practices and beliefs and their relationships to overweight in early childhood. J Dev Behav Pediatr (2001) 2.39

The effects of FK 506 on renal function after liver transplantation. Transplant Proc (1990) 2.31

Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. Transplant Proc (1991) 2.26

Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res (2001) 2.22

Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J (2002) 2.19

Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology (1999) 2.15

Late clouding of an acrylic intraocular lens following routine phacoemulsification. Eye (Lond) (1999) 2.14

Cardiovascular risk assessment of South Asians in a religious setting: a feasibility study. Int J Clin Pract (2011) 2.12

One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc (1991) 2.10

Masseter cysticercosis - a rare case diagnosed on ultrasound. Dentomaxillofac Radiol (2008) 2.09

Reduction in radiation exposure during coronary angiography. Cathet Cardiovasc Diagn (1990) 2.03

Creutzfeldt-Jakob disease : report of 10 cases from North India. Neurol India (2001) 2.02

Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet (1995) 1.96

Successful teaching in evidence-based medicine. Med Educ (2000) 1.96

BCL-6 expression during B-cell activation. Blood (1996) 1.95

Chloramphenicol-furazolidone combination in enteric fever. Indian Pediatr (1995) 1.92

Process development for the removal of lead and chromium from aqueous solutions using red mud--an aluminium industry waste. Water Res (2001) 1.89

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma. Leukemia (2010) 1.81

Infections in adult liver transplant patients under FK 506 immunosuppression. Transplant Proc (1991) 1.75

Investigating the thyroid nodule. BMJ (2009) 1.73

Toxic effects of arsenic (III) on some hematopoietic and central nervous system variables in rats and guinea pigs. J Toxicol Clin Toxicol (2001) 1.72

The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg (1996) 1.71

Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine. Transplant Proc (1991) 1.69

Effects of uracil incorporation, DNA mismatches, and abasic sites on cleavage and religation activities of mammalian topoisomerase I. J Biol Chem (1997) 1.63

The question of FK 506 nephrotoxicity after liver transplantation. Transplant Proc (1991) 1.60

Detection of immunoglobulin G (IgG) and IgM antibodies to Toxoplasma gondii: evaluation of four commercial immunoassay systems. J Clin Microbiol (1997) 1.60

Accuracy and applicability of the revised WHO classification (2009) of dengue in children seen at a tertiary healthcare facility in northern India. Infection (2013) 1.59

Septic discitis presenting following intravenous cannulation. QJM (2002) 1.58

Oral glucose tolerance test in liver recipients treated with FK 506. Transplant Proc (1990) 1.56

Ambiguous coronary angiography: clinical utility of intravascular ultrasound. Cathet Cardiovasc Diagn (1992) 1.54

Screening for visual impairment in elderly patients with hip fracture: validating a simple bedside test. Eye (Lond) (2005) 1.53

Morphological effects of coronary balloon angioplasty in vivo assessed by intravascular ultrasound imaging. Circulation (1992) 1.53

Concurrent dengue virus and Japanese encephalitis virus infection of the brain: is it co-infection or co-detection? Infection (2012) 1.52

Polymerase chain reaction vs. conventional diagnosis in fine needle aspirates of tuberculous lymph nodes. Acta Cytol (2001) 1.51

An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant (2001) 1.48

Bacteriology of neonatal septicaemia in a tertiary care hospital of northern India. Indian J Med Microbiol (2007) 1.48

Converted laparoscopic colorectal surgery. Surg Endosc (2001) 1.48

Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators. Can J Cardiol (2000) 1.47

Effect of successful treatment with amphotericin B on Histoplasma capsulatum variety capsulatum polysaccharide antigen levels in patients with AIDS and histoplasmosis. Am J Med (1992) 1.46

Oscillometric blood pressure measurements in severe pre-eclampsia: validation of the SpaceLabs 90207. Br J Obstet Gynaecol (1996) 1.46

Inherited bleeding disorders in Indian women with menorrhagia. Haemophilia (2003) 1.45

Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation (1992) 1.45

A case of extensive block during spinal anaesthesia for caesarean delivery: is there some room to go wrong? Int J Obstet Anesth (2004) 1.45

Serum CA-125 measurements > 65 U/mL. Clinical value. J Reprod Med (1997) 1.44

Coronary artery fistula related to dilatation of totally occluded vessel. Clin Cardiol (1993) 1.44

Hemicrania continua: who responds to indomethacin? Cephalalgia (2009) 1.44

Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol (2009) 1.44

Transversus abdominis plane block using the loss of resistance to air technique. Minerva Anestesiol (2012) 1.43

Glutathione is required for intestinal function. Proc Natl Acad Sci U S A (1990) 1.43

Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress. Proc Natl Acad Sci U S A (1991) 1.43

Mouse ornithine decarboxylase. Complete amino acid sequence deduced from cDNA. J Biol Chem (1985) 1.42

Radical radiotherapy and salvage cystectomy as the primary management of transitional cell carcinoma of the bladder. Results following the introduction of a CT planning technique. Clin Oncol (R Coll Radiol) (2002) 1.42

Adverse effects associated with the use of FK 506. Transplant Proc (1991) 1.41

Importance of the pedicle length measurement in reduction mammaplasty. Plast Reconstr Surg (1999) 1.41

Treatment of new pulmonary tuberculosis patients: what do allopathic doctors do in India? Int J Tuberc Lung Dis (2002) 1.40

An outbreak of rubella in chandigarh, India. Indian Pediatr (2014) 1.40

Mandibular nerve block for peri-operative pain relief using a peripheral nerve stimulator. Anaesthesia (2012) 1.40

Hypokalaemia mimicking Guillain-Barre syndrome. J Assoc Physicians India (1989) 1.39

Administration of an alginate based gastric reflux suppressant on the bioavailability of omeprazole. Indian J Med Res (2006) 1.39

Gallbladder carcinoma: experience of 116 cases. Trop Gastroenterol (2000) 1.39

Induction of ventricular tachycardia in patients with left ventricular aneurysms and no history of arrhythmia. Am J Cardiol (1988) 1.39

Methotrexate for rheumatoid arthritis. J Assoc Physicians India (1994) 1.39

Similarity of the Cin1 repetitive family of Zea mays to eukaryotic transposable elements. Nature (1984) 1.39

Thoracic epidural catheterization leading to delayed transient neurological symptoms with normal imaging findings. Acta Anaesthesiol Scand (2008) 1.38

Glutathione ester prevents buthionine sulfoximine-induced cataracts and lens epithelial cell damage. Proc Natl Acad Sci U S A (1989) 1.37

Transcription enhancer factor 1 interacts with a basic helix-loop-helix zipper protein, Max, for positive regulation of cardiac alpha-myosin heavy-chain gene expression. Mol Cell Biol (1997) 1.37

FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc (1991) 1.37

Neurologic complications of FK 506. Transplant Proc (1991) 1.34

Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg (1994) 1.33

Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity. Clin Pharmacol Ther (2009) 1.32

Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. Am J Physiol (1996) 1.30

Infections with FK 506 immunosuppression: preliminary results with primary therapy. Transplant Proc (1990) 1.30

De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl (2001) 1.30

Pharmacokinetics of FK 506 in transplant patients. Transplant Proc (1991) 1.30

Prevalence of dental caries and treatment needs in the school-going children of rural areas in Udaipur district. J Indian Soc Pedod Prev Dent (2007) 1.29

Enzymatic amplification of mini-exon-derived RNA gene spacers of Leishmania donovani: primers and probes for DNA diagnosis. Parasitology (1993) 1.29

Conformation and dynamics of single DNA molecules in parallel-plate slit microchannels. Phys Rev E Stat Nonlin Soft Matter Phys (2004) 1.29

Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase. Nat Genet (2001) 1.28

Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod (2000) 1.28

Coronary artery fistula: an abnormality affecting all age groups. Medicine (Baltimore) (1990) 1.27

Inter-animal variation and its influence on the overall precision of morphometric estimates based on nested sampling designs. J Microsc (1983) 1.27

Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant (2006) 1.26

Cross-validation of a new procedure for early screening of smoking cessation medications in humans. Clin Pharmacol Ther (2010) 1.26

Development of satranidazole mucoadhesive gel for the treatment of periodontitis. AAPS PharmSciTech (2009) 1.25